Augmedix(AUGX) - 2023 Q3 - Quarterly Report
Augmedix(AUGX)2023-11-12 16:00UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ Commission File Number: 001-40890 AUGMEDIX, INC. (Exact name of registrant as specified in its charter) | --- | --- | |---------------- ...